{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:12:36Z","timestamp":1778879556469,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177780","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T19:28:26Z","timestamp":1748374106000},"page":"177780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Combination therapy with citalopram, bupropion, and lithium for the amelioration of the depressive-related effects induced by dexamethasone in male mice"],"prefix":"10.1016","volume":"1002","author":[{"given":"Elmira","family":"Daliri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Hamyani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Arjangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Khakpai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0235-9776","authenticated-orcid":false,"given":"Sakineh","family":"Alijanpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0688-5378","authenticated-orcid":false,"given":"Mohammad-Reza","family":"Zarrindast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177780_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jpsychires.2024.02.029","article-title":"Cerebrolysin potentiates the antidepressant effect of lithium in a rat model of depression","volume":"172","author":"Abdelaty","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejphar.2025.177780_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41545-023-00238-w","article-title":"Global navigation of lithium in water bodies and emerging human health crisis","volume":"6","author":"Adeel","year":"2023","journal-title":"npj Clean Water"},{"key":"10.1016\/j.ejphar.2025.177780_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.biopha.2018.10.033","article-title":"Co-administration of the low dose of orexin and nitrergic antagonists induces an antidepressant-like effect in mice","volume":"109","author":"Alijanpour","year":"2019","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.ejphar.2025.177780_bib4","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.biopsych.2005.09.008","article-title":"Glucocorticoids and relapse of major depression (dexamethasone\/corticotropin-releasing hormone test in relation to relapse of major depression)","volume":"59","author":"Appelhof","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.177780_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jad.2005.08.016","article-title":"Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study","volume":"89","author":"Argyelan","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2025.177780_bib6","doi-asserted-by":"crossref","first-page":"101868","DOI":"10.1016\/j.gsf.2024.101868","article-title":"Lithium: a review of applications, occurrence, exploration, extraction, rercycling, analysis, and environmental impact","author":"Balaram","year":"2024","journal-title":"Geosci. Front."},{"key":"10.1016\/j.ejphar.2025.177780_bib7","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/sj.npp.1300677","article-title":"Antidepressant-like effect of D2\/3 receptor-, but not D4 receptor-activation in the rat forced swim test","volume":"30","author":"Basso","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2025.177780_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40263-014-0152-8","article-title":"Role of lithium augmentation in the management of major depressive disorder","volume":"28","author":"Bauer","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2025.177780_bib9","series-title":"146th Annual Meeting of the American Psychiatric Association, San Francisco","article-title":"The combined use of fluoxetine and bupropion","author":"Boyer","year":"1993"},{"key":"10.1016\/j.ejphar.2025.177780_bib10","article-title":"Citalopram versus other anti\u2010depressive agents for depression","author":"Cipriani","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2025.177780_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0306-4530(99)00045-1","article-title":"Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies","volume":"25","author":"Cole","year":"2000","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ejphar.2025.177780_bib12","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.07.027","article-title":"Efficacy and safety of citalopram for the treatment of poststroke depression: a MetaAnalysis","volume":"27","author":"Cui","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.ejphar.2025.177780_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00213-002-1335-4","article-title":"Antidepressant-like effects in various mice strains in the forced swimming test","volume":"166","author":"David","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2025.177780_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.psyneuen.2007.11.016","article-title":"Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder","volume":"33","author":"de Kloet","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ejphar.2025.177780_bib15","first-page":"653","article-title":"Bupropion: a review of its use in the management of major depressive disorder","volume":"68","author":"Dhillon","year":"2008","journal-title":"Drugs (Basel)"},{"key":"10.1016\/j.ejphar.2025.177780_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuro.2020.12.016","article-title":"Cognitive effects of the GSK-3 inhibitor \u201clithium\u201d in LPS\/chronic mild stress rat model of depression: hippocampal and cortical neuroinflammation and tauopathy","volume":"83","author":"Ebeid","year":"2021","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejphar.2025.177780_bib17","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1471-4159.2006.04139.x","article-title":"Chronic lithium administration to FTDP\u201017 tau and GSK\u20103\u03b2 overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre\u2010formed neurofibrillary tangles do not revert","volume":"99","author":"Engel","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2025.177780_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yfrne.2012.09.003","article-title":"Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise","volume":"33","author":"Felger","year":"2012","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2025.177780_bib19","doi-asserted-by":"crossref","DOI":"10.29333\/ejgm\/13295","article-title":"Potential strategies to optimize the efficacy of antidepressants: beyond the monoamine theory","volume":"20","author":"Gammoh","year":"2023","journal-title":"Electronic Journal of General Medicine"},{"key":"10.1016\/j.ejphar.2025.177780_bib20","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jpsychires.2013.03.006","article-title":"Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only","volume":"47","author":"Haghighi","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejphar.2025.177780_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neuroscience.2015.12.024","article-title":"Lithium attenuated the depressant and anxiogenic effect of juvenile social stress through mitigating the negative impact of interlukin-1beta and nitric oxide on hypothalamic-pituitary-adrenal axis function","volume":"315","author":"Haj-Mirzaian","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2025.177780_bib22","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2174\/1567205013666160219112712","article-title":"Neuroprotective effects of lithium in human brain? Food for thought","volume":"13","author":"Hajek","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejphar.2025.177780_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","article-title":"Monoamine neurocircuitry in depression and strategies for new treatments","volume":"45","author":"Hamon","year":"2013","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.177780_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2024.137688","article-title":"Interaction between citalopram and omega-3 fatty acids on anxiety and depression behaviors and maintaining the stability of brain pyramidal neurons in mice","volume":"824","author":"Hosseini","year":"2024","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2025.177780_bib25","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.pnpbp.2005.03.014","article-title":"The combined dexamethasone\/CRH test as a potential surrogate marker in depression","volume":"29","author":"Ising","year":"2005","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.177780_bib26","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.clinthera.2005.11.011","article-title":"Bupropion for major depressive disorder: pharmacokinetic and formulation considerations","volume":"27","author":"Jefferson","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2025.177780_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.55782\/ane-2023-017","article-title":"The effect of nicotine on antidepressant and anxiolytic responses induced by citalopram and citicoline in mice","volume":"83","author":"Khakpai","year":"2023","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.ejphar.2025.177780_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.960279","article-title":"Dexamethasone-associated metabolic effects in male mice are partially caused by depletion of endogenous corticosterone","volume":"13","author":"Koorneef","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2025.177780_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176126","article-title":"Increased depression-like behaviors with altered brain dopamine metabolisms in male mice housed in large cages are alleviated by bupropion","volume":"960","author":"Kurogi","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177780_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1016-3190(09)60071-9","article-title":"Mirtazapine and bupropion combined treatment in treatment-resistant depression","volume":"21","author":"Lai","year":"2009","journal-title":"Tzu Chi Med. J."},{"key":"10.1016\/j.ejphar.2025.177780_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4088\/JCP.v65n0308","article-title":"Citalopram and bupropion-SR: combining versus switching in patients with treatment-resistant depression","volume":"65","author":"Lam","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.177780_bib32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4088\/JCP.v65n0308","article-title":"Citalopram and bupropion-SR: combining versus switching in patients with treatment-resistant depression","volume":"65","author":"Lam","year":"2004","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.177780_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0028-3908(01)00160-5","article-title":"Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats","volume":"42","author":"Li","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.177780_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neulet.2012.07.011","article-title":"Swimming exercise ameliorates depression-like behaviors induced by prenatal exposure to glucocorticoids in rats","volume":"524","author":"Liu","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2025.177780_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2014.09.075","article-title":"Neonatal dexamethasone accelerates spreading depression in the rat, and antioxidant vitamins counteract this effect","volume":"1591","author":"Lopes-de-Morais","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2025.177780_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077227","article-title":"Synergistic effects of celecoxib and bupropion in a model of chronic inflammation-related depression in mice","volume":"8","author":"Maciel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177780_bib37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/exnr.1996.0154","article-title":"Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture","volume":"141","author":"McIntosh","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2025.177780_bib38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/1469-8986.00027","article-title":"The alerting effects of dexamethasone","volume":"40","author":"Meixner","year":"2003","journal-title":"Psychophysiology"},{"key":"10.1016\/j.ejphar.2025.177780_bib39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pnpbp.2018.07.013","article-title":"Differential effects of citalopram on sleep-deprivation-induced depressive-like behavior and memory impairments in mice","volume":"88","author":"Misrani","year":"2019","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.177780_bib40","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00210-022-02242-2","article-title":"Isobolographic analysis of the antidepressant interaction in two-drug combinations of citalopram, bupropion, and scopolamine in mice","volume":"395","author":"Mohammadi-Mahdiabadi-Hasani","year":"2022","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177780_bib41","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3390\/molecules23092197","article-title":"Resveratrol and depression in animal models: a systematic review of the biological mechanisms","volume":"23","author":"Moore","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2025.177780_bib42","first-page":"1","article-title":"Synergistic antidepressant- and anxiolytic-like effects of harmaline along with cinanserin in acute restraint stress-treated mice","author":"Mosaffa","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2025.177780_bib43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuroscience.2016.10.007","article-title":"Additive effect of harmane and muscimol for memory consolidation impairment in inhibitory avoidance task","volume":"339","author":"Nasehi","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2025.177780_bib44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nlm.2017.03.022","article-title":"Synergistic effect between D-AP5 and muscimol in the nucleus accumbens shell on memory consolidation deficit in adult male Wistar rats: an isobologram analysis","volume":"141","author":"Nasehi","year":"2017","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.ejphar.2025.177780_bib45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jad.2014.03.019","article-title":"Comparing outcomes of adjunctive treatment in depression: aripiprazole versus bupropion","volume":"162","author":"Nasr","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2025.177780_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146701","article-title":"Synergistic effect between citalopram and citicoline on anxiolytic effect in non-sensitized and morphine-sensitized mice: an isobologram analysis","volume":"1734","author":"Nejati","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2025.177780_bib47","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2165\/00023210-199708050-00009","article-title":"Citalopram: a review of its pharmacology, clinical efficacy and tolerability in the treatment of depression","volume":"8","author":"Noble","year":"1997","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2025.177780_bib48","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1073\/pnas.0500466102","article-title":"Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo","volume":"102","author":"Noble","year":"2005","journal-title":"Proceedings of the national academy of sciences"},{"key":"10.1016\/j.ejphar.2025.177780_bib49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.psyneuen.2007.10.011","article-title":"Longitudinal neuroendocrine changes assessed by dexamethasone\/CRH and growth hormone releasing hormone tests in psychotic depression","volume":"33","author":"Owashi","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ejphar.2025.177780_bib50","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.4088\/JCP.v68n1211","article-title":"Comparing the rapidity of response during treatment of major depressive disorder with bupropion and the SSRIs: a pooled survival analysis of 7 double-blind, randomized clinical trials","volume":"68","author":"Papakostas","year":"2007","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.177780_bib51","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/da.20181","article-title":"The combination of duloxetine and bupropion for treatment\u2010resistant major depressive disorder","volume":"23","author":"Papakostas","year":"2006","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.ejphar.2025.177780_bib52","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1345\/aph.19137","article-title":"Citalopram in the treatment of depression","volume":"34","author":"Parker","year":"2000","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177780_bib53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/2045125316629071","article-title":"Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant","volume":"6","author":"Patel","year":"2016","journal-title":"Therapeutic advances in psychopharmacology"},{"key":"10.1016\/j.ejphar.2025.177780_bib54","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/npp.2017.238","article-title":"The new news about lithium: an underutilized treatment in the United States","volume":"43","author":"Post","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2025.177780_bib55","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbr.2008.06.028","article-title":"Is co-administration of bupropion with SSRIs and SNRIs in forced swimming test in mice, predictive of efficacy in resistant depression?","volume":"194","author":"Prica","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2025.177780_bib56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neulet.2017.03.048","article-title":"Involvement of Akt\/GSK3\u03b2\/CREB signaling pathway on chronic omethoate induced depressive-like behavior and improvement effects of combined lithium chloride and astaxanthin treatment","volume":"649","author":"Qiao","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2025.177780_bib57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s002130100836","article-title":"Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?","volume":"159","author":"Renard","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2025.177780_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2015.10.006","article-title":"Effects of lobeline and reboxetine, fluoxetine, or bupropion combination on depression-like behaviors in mice","volume":"139","author":"Roni","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2025.177780_bib59","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jsbmb.2014.02.011","article-title":"Melatonin pretreatment prevented the effect of dexamethasone negative alterations on behavior and hippocampal neurogenesis in the mouse brain","volume":"143","author":"Ruksee","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejphar.2025.177780_bib60","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-8993(85)90638-9","article-title":"Down-regulation of neural corticosterone receptors by corticosterone and dexamethasone","volume":"339","author":"Sapolsky","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2025.177780_bib61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuroscience.2014.11.035","article-title":"Behavioral and molecular alterations in mice resulting from chronic treatment with dexamethasone: relevance to depression","volume":"286","author":"Skupio","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2025.177780_bib62","first-page":"159","article-title":"A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor","volume":"6","author":"Stahl","year":"2004","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.177780_bib63","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.psyneuen.2007.03.012","article-title":"Plasma corticosterone, dexamethasone (DEX) suppression and DEX\/CRH tests in a rat model of genetic vulnerability to depression","volume":"32","author":"Steimer","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ejphar.2025.177780_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104975","article-title":"Identifying the neuropsychiatric health effects of low-dose lithium interventions: a systematic review","volume":"144","author":"Strawbridge","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2025.177780_bib65","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1016\/j.xphs.2020.08.011","article-title":"Formulation, characterization and comparative pharmacokinetic study of bupropion floating raft system as a promising approach for treating depression","volume":"109","author":"Teaima","year":"2020","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2025.177780_bib66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0165-0327(02)00306-3","article-title":"Assessing the effects of bupropion SR on mood dimensions of depression","volume":"78","author":"Tomarken","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2025.177780_bib67","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00213-008-1311-8","article-title":"Lithium and cognitive enhancement: leave it or take it?","volume":"202","author":"Tsaltas","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2025.177780_bib68","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.euroneuro.2009.02.007","article-title":"The influence of psychiatric comorbidity on the dexamethasone\/CRH test in major depression","volume":"19","author":"Veen","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2025.177780_bib69","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1176\/appi.ajp.161.6.1079","article-title":"A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents","volume":"161","author":"Wagner","year":"2004","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.177780_bib70","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.euroneuro.2010.02.013","article-title":"Antidepressant-like effect of trans-resveratrol: involvement of serotonin and noradrenaline system","volume":"20","author":"Xu","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2025.177780_bib71","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bbrc.2004.03.071","article-title":"Differential effects of corticosterone and dexamethasone on hippocampal neurogenesis in vitro","volume":"317","author":"Yu","year":"2004","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.ejphar.2025.177780_bib72","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.biopsych.2005.06.027","article-title":"Use of bupropion in combination with serotonin reuptake inhibitors","volume":"59","author":"Zisook","year":"2006","journal-title":"Biol. Psychiatry"}],"updated-by":[{"DOI":"10.1016\/j.ejphar.2025.177835","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000}}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:27:10Z","timestamp":1778876830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925005345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":72,"alternative-id":["S0014299925005345"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177780","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination therapy with citalopram, bupropion, and lithium for the amelioration of the depressive-related effects induced by dexamethasone in male mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177780"}}